FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Amy Shapiro

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Concepts & Ideas

Treatment Outcome

Physiology

Geographic Areas

United States

Co-author Network

Publications

TOP 3
Veronica H Flood; Kenneth D Friedman; Joan Cox Gill; Sandra L Haberichter; Raymond G Hoffmann; W Keith Hoots; Cindy A Leissinger; Jeanne M Lusher; Thomas C Abshire; Brian R Branchford; Deborah L Brown; Pamela A Christopherson; Jorge Di Paola; Amy L Dunn; Margaret V Ragni; Amy D Shapiro; Robert R Montgomery
No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
M Escobar; A Forsyth; E Hellman; N Hroma; JA Maahs; D L Cooper; J Donkin; R Tachdjian; Leonard A Valentino; G Young; Amy D Shapiro
Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres.
N Duncan; J Epstein; Amy D Shapiro; X Ye; M P Luo
Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Amy Shapiro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Veronica H Flood; Kenneth D Friedman; Joan Cox Gill; Sandra L Haberichter; Raymond G Hoffmann; W Keith Hoots; Cindy A Leissinger; Jeanne M Lusher; Thomas C Abshire; Brian R Branchford; Deborah L Brown; Pamela A Christopherson; Jorge Di Paola; Amy L Dunn; Margaret V Ragni; Amy D Shapiro; Robert R Montgomery
No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation.
Blood 2013;121(18):3742-4.
2012: M Escobar; A Forsyth; E Hellman; N Hroma; JA Maahs; D L Cooper; J Donkin; R Tachdjian; Leonard A Valentino; G Young; Amy D Shapiro
Multidisciplinary management of patients with haemophilia with inhibitors undergoing surgery in the United States: perspectives and best practices derived from experienced treatment centres.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(6):971-81.
2012: N Duncan; J Epstein; Amy D Shapiro; X Ye; M P Luo
Treatment patterns, health-related quality of life and adherence to prophylaxis among haemophilia A patients in the United States.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(5):760-5.
2012: G Young; R A Gruppo; R Z Gut; Amy D Shapiro; C E Walsh; D L Cooper
Patient/caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE).
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(3):392-9.
2012: Amy D Shapiro; D L Cooper
U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(3):400-5.
2012: Daniel B Bellissimo; Pamela A Christopherson; Veronica H Flood; Kenneth D Friedman; Joan Cox Gill; Sandra L Haberichter; W Keith Hoots; Cindy Leissinger; Jeanne M Lusher; Margaret V Ragni; Amy D Shapiro; Thomas C Abshire; Robert R Montgomery
VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.
Blood 2012;119(9):2135-40.
2012: Amy D Shapiro; Arthur R Thompson; Karen L Tubridy; Leonard A Valentino; Jerry S Powell; Margaret V Ragni; Alan J Bitonti; Gregory Cheng; Jennifer A Dumont; Donald Euwart; Jaya Goyal; Peter Gozzi; Bengt Hallén; Haiyan Jiang; Neil C Josephson; Nigel S Key; Lian Li; Alvin Luk; Robert T Peters; Glenn F Pierce
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients.
Blood 2012;119(3):666-72.
2011: Diane J Aschman; Ann D Forsberg; Jeanne M Lusher; Amy D Shapiro; Thomas C Abshire; Roshni Kulkarni
A community-based partnership to promote information infrastructure for bleeding disorders.
American journal of preventive medicine 2011;41(6 Suppl 4):S332-7.
2011: Amy D Shapiro; J Michael Soucie; Diane J Aschman; Donna M DiMichele; Flora Peyvandi
Knowledge and therapeutic gaps: a public health problem in the rare coagulation disorders population.
American journal of preventive medicine 2011;41(6 Suppl 4):S324-31.
2011: Anjali Sharathkumar; J Michael Soucie; B Trawinski; A Greist; Amy D Shapiro
Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).
Haemophilia : the official journal of the World Federation of Hemophilia 2011;17(4):597-604.
2010: N Duncan; W Kronenberger; C Roberson; Amy D Shapiro
VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16(2):247-55.
2009: Roshni Kulkarni; J Michael Soucie; Jeanne M Lusher; R Presley; Amy D Shapiro; J Gill; Marilyn J Manco-Johnson; M Koerper; Prasad Mathew; Thomas C Abshire; D Dimichele; Keith Hoots; R Janco; D Nugent; S Geraghty; Bruce Evatt
Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention's (CDC) Universal Data Collection (UDC) project.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(6):1281-90.
2009: francesco bernardi; Alberto Dolce; Mirko Pinotti; Amy D Shapiro; E Santagostino; F Peyvandi; A Batorova; M Lapecorella; J F Schved; Jørgen Ingerslev; Guglielmo Mariani
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B.
Journal of thrombosis and haemostasis : JTH 2009;7(5):774-9.
2009: Amy D Shapiro; Ralph Gruppo; Ingrid Pabinger; Peter W Collins; Charles R M Hay; Phillip Schroth; Kathleen Casey; Lisa Patrone; Hartmut Ehrlich; Bruce M Ewenstein
Integrated analysis of safety and efficacy of a plasma- and albumin-free recombinant factor VIII (rAHF-PFM) from six clinical studies in patients with hemophilia A.
Expert opinion on biological therapy 2009;9(3):273-83.
2009: Anjali Sharathkumar; B Hardesty; A Greist; J Salter; B Kerlin; M Heiman; M Sulkin; Amy D Shapiro
Variability in bleeding phenotype in Amish carriers of haemophilia B with the 31008 C-->T mutation.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(1):91-100.
2008: Anjali Sharathkumar; Amy D Shapiro
Hereditary haemorrhagic telangiectasia.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(6):1269-80.
2008: R Mehta; Amy D Shapiro
Plasminogen deficiency.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(6):1261-8.
2008: R Mehta; Amy D Shapiro
Plasminogen activator inhibitor type 1 deficiency.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(6):1255-60.
2008: Amy D Shapiro
Single-dose recombinant activated factor VII for the treatment of joint bleeds in hemophilia patients with inhibitors.
Clinical advances in hematology & oncology : H&O 2008;6(8):579-86.
2008: Claude Négrier; Amy D Shapiro; Erik Berntorp; Ingrid Pabinger; Michael D. Tarantino; Anastassios Retzios; Phillip Schroth; Bruce Ewenstein
Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients.
Thrombosis and haemostasis 2008;100(2):217-23.
2008: Victor S Blanchette; Amy D Shapiro; R J Liesner; F Hernández Navarro; Indira Warrier; Phillip Schroth; G Spotts; B M Ewenstein
Plasma and albumin-free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients.
Journal of thrombosis and haemostasis : JTH 2008;6(8):1319-26.
2008: A Sharthkumar; A Greist; Jorge Di Paola; J Winay; C Roberson; M Heiman; S Herbert; R Parameswaran; Amy D Shapiro
Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(3):539-48.
2007: Thomas Tencer; C Roberson; N Duncan; Kathleen Johnson; Amy D Shapiro
A haemophilia treatment centre-administered disease management programme in patients with bleeding disorders.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(5):480-8.
2007: Marilyn J Manco-Johnson; Thomas C Abshire; Amy D Shapiro; Brenda Riske; Michele R Hacker; Ray F Kilcoyne; J David Ingram; Michael L Manco-Johnson; Sharon Funk; Linda Jacobson; Leonard A Valentino; W Keith Hoots; George R Buchanan; Donna DiMichele; Michael Recht; Deborah Brown; Cindy A Leissinger; Shirley Bleak; ALAN COHEN; Prasad Mathew; Alison Matsunaga; Desiree Medeiros; Diane J Nugent; Gregory A Thomas; Alexis A Thompson; Kevin P. McRedmond; J Michael Soucie; Harlan Austin; Bruce Evatt
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
The New England journal of medicine 2007;357(6):535-44.
2007: Michele R Hacker; John H Page; Amy D Shapiro; Janet W Rich-Edwards; Marilyn J Manco-Johnson
Central venous access device infections in children with hemophilia: a comparison of prophylaxis and episodic therapy.
Journal of pediatric hematology/oncology 2007;29(7):458-64.
2007: Sharyne Donfield; Amy D Shapiro; Edward D Gomperts; Henry S Lynn; Dale Usner
The parachute must be properly folded ...
Journal of thrombosis and haemostasis : JTH 2007;5(3):646-7.
2007: Amy D Shapiro
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE) in the management of hemophilia A.
Vascular health and risk management 2007;3(5):555-65.
2006: R Mehta; R Parameswaran; Amy D Shapiro
An overview of the history, clinical practice concerns, comparative studies and strategies to optimize therapy of bypassing agents.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12 Suppl 6():54-61.
2006: Erik Berntorp; Amy D Shapiro; Jan Astermark; Victor S Blanchette; Peter W Collins; Donna DiMichele; C Escuriola; C R M Hay; W Keith Hoots; Cindy A Leissinger; Claude Negrier; Johannes Oldenburg; Kathelijne Peerlinck; M T Reding; C Hart
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12 Suppl 6():1-7.
2005: Amy D Shapiro; J Korth-Bradley; M-C Poon
Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(6):571-82.
2005: E Berntorp; Jan Astermark; Sharyne Donfield; George W Nelson; J Oldenburg; Amy D Shapiro; Donna DiMichele; Bruce M Ewenstein; Edward D Gomperts; C A Winkler
Haemophilia Inhibitor Genetics Study - evaluation of a model for studies of complex diseases using linkage and association methods.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(4):427-9.
2005: Sharyne Donfield; Amy D Shapiro; Edward D Gomperts; Henry S Lynn
Haemophilia-related morbidity and quality-of-life.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(4):418.
2005: Ellen L Pratt; Michael D. Tarantino; Debra Wagner; Ora Hirsch Pescovitz; Suzanne Bowyer; Amy D Shapiro
Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura.
American journal of hematology 2005;79(3):175-9.
2005: R Parameswaran; Amy D Shapiro; Joan Cox Gill; Craig M Kessler
Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(2):100-6.
2005: Craig M Kessler; Joan Cox Gill; Gilbert C White; Amy D Shapiro; S Arkin; D A Roth; X Meng; Jeanne M Lusher
B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(2):84-91.
2005: Amy D Shapiro; Jorge Di Paola; Alice Cohen; K John Pasi; Margaret A Heisel; Victor S Blanchette; Thomas C Abshire; W Keith Hoots; Jeanne M Lusher; Claude Negrier; Chantal Rothschild; David A Roth
The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B.
Blood 2005;105(2):518-25.
2004: Bruce M Ewenstein; Leonard A Valentino; Janna M Journeycake; Michael D. Tarantino; Amy D Shapiro; Victor S Blanchette; W Keith Hoots; George R Buchanan; Marilyn J Manco-Johnson; Georges-Etienne Rivard; Kim L Miller; Susan J Geraghty; JA Maahs; R Stuart; T Dunham; Roberta Navickis Wilkes
Consensus recommendations for use of central venous access devices in haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10(5):629-48.
2004: Michael D. Tarantino; Peter W Collins; C R M Hay; Amy D Shapiro; R A Gruppo; E Berntorp; G L Bray; S A Tonetta; Phillip Schroth; Anastassios Retzios; S S Rogy; M G Sensel; Bruce M Ewenstein
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10(5):428-37.
2004: Bruce M Ewenstein; P Collins; Michael D. Tarantino; Claude Negrier; V Blanchette; Amy D Shapiro; D Baker; G Spotts; M Sensel; S E Yi; Edward D Gomperts
Hemophilia therapy innovation: development of an advanced category recombinant factor VIII by a plasma/albumin-free method. Proceedings of a Special Symposium at the XIXth Congress of the International Society on Thrombosis and Haemostasis, July 12-18, 2003, Birmingham, UK.
Seminars in hematology 2004;41(1 Suppl 2):1-16; discussion 16-8.
2003: Amy D Shapiro
Why is primary prophylaxis underutilized in the United States?
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9(6):670-2.
2003: Michael D. Tarantino; Alice Lail; Sharyne Donfield; Henry S Lynn; L Peddle; S Hunsberger; Amy D Shapiro
Surveillance of infectious complications associated with central venous access devices in children with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9(5):588-92.
2003: Jan Astermark; J Voorberg; Harald Lenk; Donna DiMichele; Amy D Shapiro; G Tjönnfjord; Erik Berntorp
Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitro.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9(5):567-72.
2003: Amy D Shapiro
A global view on prophylaxis: possibilities and consequences.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9 Suppl 1():10-7; discussion 18.
2003: Erik Berntorp; Jan Astermark; Sven Björkman; Victor S Blanchette; K Fischer; P L F Giangrande; Alessandro Gringeri; Rolf Ljung; Marilyn J Manco-Johnson; Massimo Morfini; Ray F Kilcoyne; P Petrini; E Carlos Rodriguez-Merchan; W Schramm; Amy D Shapiro; H Marijke van den Berg; C Hart
Consensus perspectives on prophylactic therapy for haemophilia: summary statement.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9 Suppl 1():1-4.
2003: Prasad Mathew; A Greist; JA Maahs; E C Lichtenberg; Amy D Shapiro
Type 2B vWD: the varied clinical manifestations in two kindreds.
Haemophilia : the official journal of the World Federation of Hemophilia 2003;9(1):137-44.
2003: Amy D Shapiro
Inhibitor treatment: state of the art.
Disease-a-month : DM 2003;49(1):22-38.
2002: Bruce Evatt; A Farrugia; Amy D Shapiro; J T Wilde
Haemophilia 2002: emerging risks of treatment.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(3):221-9.
2002: Bruce M Ewenstein; J Heinrich Joist; Amy D Shapiro; Thomas C Hofstra; Cindy A Leissinger; Stephanie V Seremetis; Martin Broder; Guenther Mueller-Velten; Bruce A Schwartz
Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B.
Transfusion 2002;42(2):190-7.
2001: Amy D Shapiro; Sharyne Donfield; Henry S Lynn; VA Cool; James A Stehbens; S L Hunsberger; S Tonetta; Edward D Gomperts
Defining the impact of hemophilia: the Academic Achievement in Children with Hemophilia Study.
Pediatrics 2001;108(6):E105.
2001: Amy D Shapiro
Inhibitor treatment: state of the art.
Seminars in hematology 2001;38(4 Suppl 12):26-34.
2001: Sven Björkman; Amy D Shapiro; Erik Berntorp
Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis.
Haemophilia : the official journal of the World Federation of Hemophilia 2001;7(2):133-9.
2000: Amy D Shapiro
Platelet function disorders.
Haemophilia : the official journal of the World Federation of Hemophilia 2000;6 Suppl 1():120-7.
2000: AC Wiestner; S A Padosch; Nico Ghilardi; Jesús M Cesar; J Odriozola; Amy D Shapiro; Radek C Skoda
Hereditary thrombocythaemia is a genetically heterogeneous disorder: exclusion of TPO and MPL in two families with hereditary thrombocythaemia.
British journal of haematology 2000;110(1):104-9.
2000: Amy D Shapiro
Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors.
Seminars in thrombosis and hemostasis 2000;26(4):413-9.
2000: CP Engelfriet; Henk W Reesink; P M Mannucci; Alessandro Gringeri; Jørgen Ingerslev; D B Brettler; Eveline P Mauser-Bunschoten; Claude Negrier; E Berntorp; O P Smith; Amy D Shapiro
The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies.
Vox sanguinis 2000;78(4):256-61.
1999: Amy D Shapiro
Recombinant factor VIIa: a viewpoint by Amy D. Shapiro.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1999;12(1):78-9.
1999: Erik C Thorland; Joni B Drost; Jeanne M Lusher; Indira Warrier; Amy D Shapiro; Marion A Koerper; Donna DiMichele; J Westman; Nigel S Key; Steve S Sommer
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest risk.
Haemophilia : the official journal of the World Federation of Hemophilia 1999;5(2):101-5.
1998: Nigel S Key; LM Aledort; D Beardsley; Herbert Cooper; G Davignon; Bruce M Ewenstein; GS Gilchrist; Joan Cox Gill; Bertil E Glader; W Keith Hoots; CT Kisker; Jeanne M Lusher; C G Rosenfield; Amy D Shapiro; H Smith; E Taft
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Thrombosis and haemostasis 1998;80(6):912-8.
1998: Jeanne M Lusher; Harold R Roberts; G Davignon; J H Joist; H Smith; Amy D Shapiro; Y Laurian; C K Kasper; P M Mannucci
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(6):790-8.
1998: Amy D Shapiro; GS Gilchrist; W Keith Hoots; Herbert Cooper; Dennis A Gastineau
Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery.
Thrombosis and haemostasis 1998;80(5):773-8.
1998: G White; Amy D Shapiro; M Ragni; P Garzone; J Goodfellow; K Tubridy; S Courter
Clinical evaluation of recombinant factor IX.
Seminars in hematology 1998;35(2 Suppl 2):33-8.
1998: S Arkin; Herbert Cooper; J J Hutter; S Miller; Mary Lou Schmidt; N L Seibel; Amy D Shapiro; Indira Warrier
Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program.
Haemostasis 1998;28(2):93-8.
1997: William P Fay; Andrew C Parker; L R Condrey; Amy D Shapiro
Human plasminogen activator inhibitor-1 (PAI-1) deficiency: characterization of a large kindred with a null mutation in the PAI-1 gene.
Blood 1997;90(1):204-8.
1997: Indira Warrier; Bruce M Ewenstein; Marion A Koerper; Amy D Shapiro; Nigel S Key; Donna DiMichele; R T Miller; John Pasi; Georges-Etienne Rivard; Steve S Sommer; J Katz; F Bergmann; Rolf Ljung; P Petrini; Jeanne M Lusher
Factor IX inhibitors and anaphylaxis in hemophilia B.
Journal of pediatric hematology/oncology 1997;19(1):23-7.
1996: D Menache; D L Aronson; F Darr; R R Montgomery; J C Gill; C M Kessler; Jeanne M Lusher; P D Phatak; Amy D Shapiro; A R Thompson; G C White
Pharmacokinetics of von Willebrand factor and factor VIIIC in patients with severe von Willebrand disease (type 3 VWD): estimation of the rate of factor VIIIC synthesis. Cooperative Study Groups.
British journal of haematology 1996;94(4):740-5.
1996: Amy D Shapiro
American experience with home use of NovoSeven: recombinant factor VIIa in hemophiliacs with inhibitors.
Haemostasis 1996;26 Suppl 1():143-9.
1996: Amy D Shapiro; M V Ragni; Jeanne M Lusher; S Culbert; Marion A Koerper; G E Bergman; M M Hannan
Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B.
Thrombosis and haemostasis 1996;75(1):30-5.
1995: Amy D Shapiro
Antithrombin deficiency in special clinical syndromes--Part I: neonatal and pediatric/physiologic deficiency: extracorporeal membrane oxygenation.
Seminars in hematology 1995;32(4 Suppl 2):33-6.
1995: Indira Warrier; C K Kasper; G C White; Amy D Shapiro; G E Bergman
Safety of high doses of a monoclonal antibody-purified factor IX concentrate. The Mononine Study Group.
American journal of hematology 1995;49(1):92-4.
1995: G C White; Amy D Shapiro; E M Kurczynski; H C Kim; G E Bergman
Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
Thrombosis and haemostasis 1995;73(5):779-84.
1995: Amy D Shapiro; T Abe; L M Aledort; K Anderle; M W Hilgartner; M Kunschak; F E Preston; G E Rivard; K Schimpf
Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group.
Transfusion 1995;35(3):204-8.
1994: B J Sanders; Amy D Shapiro; C G McKown
The case of good luck.
Pediatric dentistry 1994;16(6):402.
1994: J M Gertner; F R Kaufman; Sharyne Donfield; L A Sleeper; Amy D Shapiro; C Howard; E D Gomperts; M W Hilgartner
Delayed somatic growth and pubertal development in human immunodeficiency virus-infected hemophiliac boys: Hemophilia Growth and Development Study.
The Journal of pediatrics 1994;124(6):896-902.
1994: G L Bray; Edward D Gomperts; S Courter; Ralph A Gruppo; E M Gordon; M Manco-Johnson; Amy D Shapiro; E Scheibel; G White; M Lee
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.
Blood 1994;83(9):2428-35.
1994: L K Tanimura; J A Weddell; C G McKown; Amy D Shapiro; J Mulherin
Oral management of a patient with a plasminogen activator inhibitor (PAI-1) deficiency: case report.
Pediatric dentistry 1994;16(2):133-5.
1994: William P Fay; Daniel T Eitzman; Amy D Shapiro; E L Madison; David Ginsburg
Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.
Blood 1994;83(2):351-6.
1994: Amy D Shapiro
Long-term surveillance of HIV, HBV, and HCV infected patients.
Annals of hematology 1994;68 Suppl 3():S87-8.
1993: Amy D Shapiro; S L Clarke; J M Christian; Lorrie F Odom; W E Hathaway
Thrombosis in children receiving L-asparaginase. Determining patients at risk.
The American journal of pediatric hematology/oncology 1993;15(4):400-5.
1993: C D Bottema; Rhett P Ketterling; E Vielhaber; H S Yoon; B Gostout; D P Jacobson; Amy D Shapiro; Steve S Sommer
The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene.
Human genetics 1993;91(5):496-503.
1992: William P Fay; Amy D Shapiro; J L Shih; R R Schleef; David Ginsburg
Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation.
The New England journal of medicine 1992;327(24):1729-33.
1992: Sue Kenwrick; Barbara Levinson; S Taylor; Amy D Shapiro; Jane Gitschier
Isolation and sequence of two genes associated with a CpG island 5' of the factor VIII gene.
Human molecular genetics 1992;1(3):179-86.
1991: Kathleen Cooney; William C Nichols; M E Bruck; W F Bahou; Amy D Shapiro; E J Bowie; H R Gralnick; David Ginsburg
The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain.
The Journal of clinical investigation 1991;87(4):1227-33.
1991: C G McKown; Amy D Shapiro
Oral management of patients with bleeding disorders. 2. Dental considerations.
Journal (Indiana Dental Association) 1991;70(2):16-21.
1991: Amy D Shapiro; C G McKown
Oral management of patients with bleeding disorders. Part 1: Medical considerations.
Journal (Indiana Dental Association) 1991;70(1):28-31.
1990: Karen L Roos; Robert M Pascuzzi; M A Kuharik; Amy D Shapiro; Marilyn J Manco-Johnson
Postpartum intracranial venous thrombosis associated with dysfunctional protein C and deficiency of protein S.
Obstetrics and gynecology 1990;76(3 Pt 2):492-4.
1990: P A Lane; Frans A Kuypers; M R Clark; D A Andrews; G M Wagner; P Butikofer; Amy D Shapiro; D T Chiu; Bertram H Lubin; W C Mentzer
Excess of red cell membrane proteins in hereditary high-phosphatidylcholine hemolytic anemia.
American journal of hematology 1990;34(3):186-92.
1990: C D Bottema; D D Koeberl; Rhett P Ketterling; E J Bowie; S A Taylor; David Lillicrap; Amy D Shapiro; G Gilchrist; Steve S Sommer
A past mutation at isoleucine 397 is now a common cause of moderate/mild haemophilia B.
British journal of haematology 1990;75(2):212-6.
1986: Amy D Shapiro; Linda J Jacobson; M E Armon; Marilyn J Manco-Johnson; P Hulac; P A Lane; W E Hathaway
Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors.
The Journal of pediatrics 1986;109(4):675-80.